MGI Automated & Integrated Container Laboratory

MGI Latvia

The MGI Automated & Integrated Container Laboratory is capable of processing 3,000 patient samples per day.


The container lab is built in a 12-meter shipping container and equipped with automation equipment produced by MGI enabling the laboratory technicians to perform Covid-19 testing. The container lab is divided into three main areas, reagent storage & preparation, sample analysis and testing. The Biosafety Level 2 laboratory is equipped with the state-of-the-art ventilation systems for air exchange and pressure control and sterilization.


Thanks to the process automation, the container lab significantly reduces the infection risk for the laboratory technicians. The MGI automated process includes sample scanning, transfer and viral RNA extraction, the final step of sample preparation to test for the COVID-19 virus. The container lab not only provides a testing capacity of up to 3,000 samples a day, but also minimizes the manual process. It takes only three laboratory technicians to finish the whole process, whilst it would need dozens of technicians to process the same number of samples. 


The laboratory can be customized to include a genetic sequencer for Covid-19 mutation tracking. Additionally the laboratory can be used to analyze samples containing other diseases besides Covid-19, making it a long-term strategic investment. 

Manufacturer information

MGI is committed to building core tools and technology to lead life science through intelligent innovation. MGI focuses on R&D, production and sales of DNA sequencing instrumentsreagents, and related products to support life science research, agriculture, forensics, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.